Retrospective Study
Copyright ©The Author(s) 2025.
World J Clin Oncol. Mar 24, 2025; 16(3): 101681
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.101681
Table 1 Basic patient information
Classification
Number
%
Age62.3 ± 10.4-
Sex
    Male3577.8
    Female1022.2
Primary tumor
    Primary liver cancer1942.3
    Lung cancer1533.3
    Cholangiocarcinoma36.7
    Esophageal cancer24.4
    Pheochromocytoma12.2
    Multiple myeloma12.2
    Colon cancer12.2
    Nasopharyngeal carcinoma36.7
Site of bone metastases
    Rib2044.4
    Shoulder blade1635.6
    Ilium920
Lesion size
    < 3 cm1328.9
    ≥ 3 cm3271.1
Nature of the lesion
    Osteolytic4088.9
    Osteogenic00
    Hybrid511.1
Table 2 Target lesion tumor treatment response assessment, n (%)
Variable
CR
PR
SD
PD
ORR
DCR
mRECIST0 (0)23 (51.1)17 (37.8)5 (11.1)23 (51.1)40 (88.9)
RECIST v1.10 (0)12 (26.7)28 (62.2)5 (11.1)12 (26.7)40 (88.9)